Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease

Monika Drożdż1, Anna Moczulska1, Andrzej Rudziński2

  • 1Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Kraków, Poland.

PubMed

Insights

Metabolic syndrome (MS) and hypertension are key risk factors for left ventricular hypertrophy (LVH) in children with chronic kidney disease (CKD). Growth deficit also significantly contributes to LVH development in this vulnerable population.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Metabolic Disorders

Background:

  • Metabolic syndrome (MS) is prevalent in children with chronic kidney disease (CKD).
  • Left ventricular hypertrophy (LVH) is a significant cardiovascular risk in CKD patients.
  • Identifying LVH risk factors in pediatric CKD is crucial for cardiovascular risk management.

Purpose of the Study:

  • To determine the most significant risk factors for left ventricular hypertrophy (LVH) in children suffering from chronic kidney disease (CKD).

Main Methods:

  • 71 children with CKD stages 1-5 underwent evaluation.
  • Metabolic syndrome (MS) diagnosed using De Ferranti (DF) criteria.
  • Echocardiography, ambulatory blood pressure monitoring (ABPM), and laboratory tests were performed.

Main Results:

  • Left ventricular hypertrophy (LVH) was detected in 29.6% of the children.
  • Metabolic syndrome (MS) diagnosis (OR=24.11), high mean arterial pressure (MAP SDS) (OR=2.812), and low height SDS (OR=0.078) were significant predictors of LVH.
  • CKD stage 5 and low height SDS were strongest univariate risk factors.

Conclusions:

  • Metabolic syndrome (MS), hypertension, advanced CKD stage, and growth deficit are significant contributors to LVH in pediatric CKD.
  • These findings highlight the multifactorial nature of LVH in children with CKD.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
43
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
42
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
29